125 related articles for article (PubMed ID: 19432851)
1. Comparison of intravenous iron sucrose versus low-molecular-weight iron dextran in chronic kidney disease.
Sinha S; Chiu DY; Peebles G; Kolakkat S; Lamerton E; Fenwick S; Kalra PA
J Ren Care; 2009 Jun; 35(2):67-73. PubMed ID: 19432851
[TBL] [Abstract][Full Text] [Related]
2. A multicentre prospective double blinded randomised controlled trial of intravenous iron (ferric Derisomaltose (FDI)) in Iron deficient but not anaemic patients with chronic kidney disease on functional status.
Bhandari S; Allgar V; Lamplugh A; Macdougall I; Kalra PA
BMC Nephrol; 2021 Mar; 22(1):115. PubMed ID: 33784968
[TBL] [Abstract][Full Text] [Related]
3. Iron Sucrose: A Wealth of Experience in Treating Iron Deficiency.
Macdougall IC; Comin-Colet J; Breymann C; Spahn DR; Koutroubakis IE
Adv Ther; 2020 May; 37(5):1960-2002. PubMed ID: 32297281
[TBL] [Abstract][Full Text] [Related]
4. Beyond efficacy and safety-the need for convenient and cost-effective iron therapy in health care.
Bhandari S
NDT Plus; 2011 Jun; 4(Suppl 1):i14-i19. PubMed ID: 27045221
[TBL] [Abstract][Full Text] [Related]
5. Anaphylactic Shock Secondary to Intravenous Iron Sucrose in Chronic Kidney Disease.
Behera V; Chauhan R; Sinha S; Nair V
Indian J Hematol Blood Transfus; 2015 Sep; 31(3):391-3. PubMed ID: 26085728
[TBL] [Abstract][Full Text] [Related]
6. Comparisons of the Efficacy and Safety of Finasteride and Dutasteride for Benign Prostatic Hyperplasia: A Network Meta-Analysis.
Yin T; Qiao Z; Li Y; Li D; Jiang M; An C; Wang F; Zuo M; Hu K; Li Q
Am J Ther; 2017; 24(5):e517-e523. PubMed ID: 26322675
[TBL] [Abstract][Full Text] [Related]
7. Comparison of dutasteride and finasteride for treating benign prostatic hyperplasia: the Enlarged Prostate International Comparator Study (EPICS).
Nickel JC; Gilling P; Tammela TL; Morrill B; Wilson TH; Rittmaster RS
BJU Int; 2011 Aug; 108(3):388-94. PubMed ID: 21631695
[TBL] [Abstract][Full Text] [Related]
8. Perioperative Use of Clevidipine: A Systematic Review and Meta-Analysis.
Espinosa A; Ripollés-Melchor J; Casans-Francés R; Abad-Gurumeta A; Bergese SD; Zuleta-Alarcon A; López-Timoneda F; Calvo-Vecino JM;
PLoS One; 2016; 11(3):e0150625. PubMed ID: 27018586
[TBL] [Abstract][Full Text] [Related]
9. Comparative efficacy and safety of medical treatments for the management of overactive bladder: a systematic literature review and mixed treatment comparison.
Maman K; Aballea S; Nazir J; Desroziers K; Neine ME; Siddiqui E; Odeyemi I; Hakimi Z
Eur Urol; 2014 Apr; 65(4):755-65. PubMed ID: 24275310
[TBL] [Abstract][Full Text] [Related]
10. Comparative Risk of Anaphylactic Reactions Associated With Intravenous Iron Products.
Wang C; Graham DJ; Kane RC; Xie D; Wernecke M; Levenson M; MaCurdy TE; Houstoun M; Ryan Q; Wong S; Mott K; Sheu TC; Limb S; Worrall C; Kelman JA; Reichman ME
JAMA; 2015 Nov; 314(19):2062-8. PubMed ID: 26575062
[TBL] [Abstract][Full Text] [Related]
11. Single dose dipyrone (metamizole) for acute postoperative pain in adults.
Hearn L; Derry S; Moore RA
Cochrane Database Syst Rev; 2016 Apr; 4(4):CD011421. PubMed ID: 27096578
[TBL] [Abstract][Full Text] [Related]
12. Non-prescription (OTC) oral analgesics for acute pain - an overview of Cochrane reviews.
Moore RA; Wiffen PJ; Derry S; Maguire T; Roy YM; Tyrrell L
Cochrane Database Syst Rev; 2015 Nov; 2015(11):CD010794. PubMed ID: 26544675
[TBL] [Abstract][Full Text] [Related]
13. Nifedipine versus atosiban for threatened preterm birth (APOSTEL III): a multicentre, randomised controlled trial.
van Vliet EOG; Nijman TAJ; Schuit E; Heida KY; Opmeer BC; Kok M; Gyselaers W; Porath MM; Woiski M; Bax CJ; Bloemenkamp KWM; Scheepers HCJ; Jacquemyn Y; Beek EV; Duvekot JJ; Franssen MTM; Papatsonis DN; Kok JH; van der Post JAM; Franx A; Mol BW; Oudijk MA
Lancet; 2016 May; 387(10033):2117-2124. PubMed ID: 26944026
[TBL] [Abstract][Full Text] [Related]
14. Comparison of adverse-event profiles of intravenous low-molecular-weight iron dextran and iron sucrose in peritoneal dialysis patients.
Solak Y; Atalay H; Guney I; Turkmen K; Kaya E; Turk S
Ren Fail; 2011; 33(3):307-11. PubMed ID: 21401355
[TBL] [Abstract][Full Text] [Related]
15. Safety profiles of total dose infusion of low-molecular-weight iron dextran and high-dose iron sucrose in renal patients.
Atalay H; Solak Y; Acar K; Govec N; Turk S
Hemodial Int; 2011 Jul; 15(3):374-8. PubMed ID: 21564503
[TBL] [Abstract][Full Text] [Related]
16. Oxytocin receptor antagonists for inhibiting preterm labour.
Flenady V; Reinebrant HE; Liley HG; Tambimuttu EG; Papatsonis DN
Cochrane Database Syst Rev; 2014 Jun; 2014(6):CD004452. PubMed ID: 24903678
[TBL] [Abstract][Full Text] [Related]
17. Calcium channel blockers for inhibiting preterm labour and birth.
Flenady V; Wojcieszek AM; Papatsonis DN; Stock OM; Murray L; Jardine LA; Carbonne B
Cochrane Database Syst Rev; 2014 Jun; 2014(6):CD002255. PubMed ID: 24901312
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of dutasteride for the treatment of symptomatic benign prostatic hyperplasia (BPH): a systematic review and meta-analysis.
Park T; Choi JY
World J Urol; 2014 Aug; 32(4):1093-105. PubMed ID: 24500194
[TBL] [Abstract][Full Text] [Related]
19. Evidence-based pharmacotherapy of panic disorder: an update.
Batelaan NM; Van Balkom AJ; Stein DJ
Int J Neuropsychopharmacol; 2012 Apr; 15(3):403-15. PubMed ID: 21733234
[TBL] [Abstract][Full Text] [Related]
20. Treatment of mood disorders in multiple sclerosis.
Pérez LP; González RS; Lázaro EB
Curr Treat Options Neurol; 2015 Jan; 17(1):323. PubMed ID: 25398464
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
